Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.
about
Combination of carbonic anhydrase inhibitor, acetazolamide, and sulforaphane, reduces the viability and growth of bronchial carcinoid cell lines.The molecular pathogenesis and management of bronchial carcinoids.Retrospective analysis of seventy-one patients with neuroendocrine tumor and review of the literature.Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch.Epigenetic changes in gastroenteropancreatic neuroendocrine tumours.NETs: organ-related epigenetic derangements and potential clinical applications.Valproic acid induces NET cell growth arrest and enhances tumor suppression of the receptor-targeted peptide-drug conjugate via activating somatostatin receptor type II.Lithium chloride suppresses colorectal cancer cell survival and proliferation through ROS/GSK-3β/NF-κB signaling pathwaySorafenib and lithium chloride combination treatment shows promising synergistic effects in human glioblastoma multiforme cells in vitro but midkine is not implicated.Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer.Does valproic acid induce neuroendocrine differentiation in prostate cancer?Identification of a novel Raf-1 pathway activator that inhibits gastrointestinal carcinoid cell growth.Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective.Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets.Histone Deacetylase Inhibitor SAHA Is a Promising Treatment of Cushing Disease.Epigenetics of Metabolic Syndrome as a Mood Disorder.Effects of Two-by-Two Combination Therapy with Valproic Acid, Lithium Chloride, and Celecoxib on the Angiogenesis of the Chicken Chorioallantoic Membrane
P2860
Q34911416-BCF5A0AB-6ADE-449B-82FC-D08C4395C5C4Q37833109-1451F9A2-20F4-4E9F-96D7-532FF8DD59D3Q37880665-50AD1AC1-F54E-4DCE-85E5-1EF540D6C31CQ37985518-14563EC9-88BA-4400-9CF6-1B88D5560EF4Q38272919-85D5711D-65DD-412A-87AC-1CC1168DDC37Q38841735-54AE1630-12FA-46FF-9847-EF60F9B8F90FQ38849324-07BE564F-E288-44B8-B9B9-8CD5EBE9A3A8Q38977253-952C2B7E-F851-4CC8-B8B6-510464443BEAQ39025471-B6DA2CE6-42B3-43D9-A3AC-DE92FAF913CAQ39034721-E67E0910-4CDE-4F4B-BD86-3ED733327F21Q39638991-BBC6677C-42EB-4641-9E7F-B5EE8DCDC30BQ39747646-8C96F83D-5F95-4C68-8FDB-0627AAD121E5Q42115029-9E3952C8-9D2E-4807-8E9E-40BB46ECE9A5Q47393972-46631FB7-3482-478C-ADA6-92CB9C7583A5Q50646949-092E546B-239B-485B-A576-F288A7A8239EQ55273449-BAD8BEC8-B261-4A65-8437-CCF3F1C9440AQ58776363-F4EB4AA1-EFD8-4E05-817B-C5D97C56D890
P2860
Combination therapy with histone deacetylase inhibitors and lithium chloride: a novel treatment for carcinoid tumors.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Combination therapy with histo ...... reatment for carcinoid tumors.
@en
Combination therapy with histo ...... reatment for carcinoid tumors.
@nl
type
label
Combination therapy with histo ...... reatment for carcinoid tumors.
@en
Combination therapy with histo ...... reatment for carcinoid tumors.
@nl
prefLabel
Combination therapy with histo ...... reatment for carcinoid tumors.
@en
Combination therapy with histo ...... reatment for carcinoid tumors.
@nl
P2860
P1476
Combination therapy with histo ...... reatment for carcinoid tumors.
@en
P2093
Daniel G Hottinger
Herbert Chen
P2860
P2888
P304
P356
10.1245/S10434-008-0194-6
P577
2008-11-22T00:00:00Z
P5875
P6179
1022747476